Cargando…

Prevention and Management Strategies for Diabetic Neuropathy

Diabetic neuropathy (DN) is a common complication of diabetes that is becoming an increasing concern as the prevalence of diabetes rapidly rises. There are several types of DN, but the most prevalent and studied type is distal symmetrical polyneuropathy, which is the focus of this review and is simp...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Sasha, Normahani, Pasha, Lane, Tristan, Hohenschurz-Schmidt, David, Oliver, Nick, Davies, Alun Huw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410148/
https://www.ncbi.nlm.nih.gov/pubmed/36013364
http://dx.doi.org/10.3390/life12081185
_version_ 1784775024053321728
author Smith, Sasha
Normahani, Pasha
Lane, Tristan
Hohenschurz-Schmidt, David
Oliver, Nick
Davies, Alun Huw
author_facet Smith, Sasha
Normahani, Pasha
Lane, Tristan
Hohenschurz-Schmidt, David
Oliver, Nick
Davies, Alun Huw
author_sort Smith, Sasha
collection PubMed
description Diabetic neuropathy (DN) is a common complication of diabetes that is becoming an increasing concern as the prevalence of diabetes rapidly rises. There are several types of DN, but the most prevalent and studied type is distal symmetrical polyneuropathy, which is the focus of this review and is simply referred to as DN. It can lead to a wide range of sensorimotor and psychosocial symptoms and is a major risk factor for diabetic foot ulceration and Charcot neuropathic osteoarthropathy, which are associated with high rates of lower limb amputation and mortality. The prevention and management of DN are thus critical, and clinical guidelines recommend several strategies for these based on the best available evidence. This article aims to provide a narrative review of DN prevention and management strategies by discussing these guidelines and the evidence that supports them. First, the epidemiology and diverse clinical manifestations of DN are summarized. Then, prevention strategies such as glycemic control, lifestyle modifications and footcare are discussed, as well as the importance of early diagnosis. Finally, neuropathic pain management strategies and promising novel therapies under investigation such as neuromodulation devices and nutraceuticals are reviewed.
format Online
Article
Text
id pubmed-9410148
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94101482022-08-26 Prevention and Management Strategies for Diabetic Neuropathy Smith, Sasha Normahani, Pasha Lane, Tristan Hohenschurz-Schmidt, David Oliver, Nick Davies, Alun Huw Life (Basel) Review Diabetic neuropathy (DN) is a common complication of diabetes that is becoming an increasing concern as the prevalence of diabetes rapidly rises. There are several types of DN, but the most prevalent and studied type is distal symmetrical polyneuropathy, which is the focus of this review and is simply referred to as DN. It can lead to a wide range of sensorimotor and psychosocial symptoms and is a major risk factor for diabetic foot ulceration and Charcot neuropathic osteoarthropathy, which are associated with high rates of lower limb amputation and mortality. The prevention and management of DN are thus critical, and clinical guidelines recommend several strategies for these based on the best available evidence. This article aims to provide a narrative review of DN prevention and management strategies by discussing these guidelines and the evidence that supports them. First, the epidemiology and diverse clinical manifestations of DN are summarized. Then, prevention strategies such as glycemic control, lifestyle modifications and footcare are discussed, as well as the importance of early diagnosis. Finally, neuropathic pain management strategies and promising novel therapies under investigation such as neuromodulation devices and nutraceuticals are reviewed. MDPI 2022-08-03 /pmc/articles/PMC9410148/ /pubmed/36013364 http://dx.doi.org/10.3390/life12081185 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Smith, Sasha
Normahani, Pasha
Lane, Tristan
Hohenschurz-Schmidt, David
Oliver, Nick
Davies, Alun Huw
Prevention and Management Strategies for Diabetic Neuropathy
title Prevention and Management Strategies for Diabetic Neuropathy
title_full Prevention and Management Strategies for Diabetic Neuropathy
title_fullStr Prevention and Management Strategies for Diabetic Neuropathy
title_full_unstemmed Prevention and Management Strategies for Diabetic Neuropathy
title_short Prevention and Management Strategies for Diabetic Neuropathy
title_sort prevention and management strategies for diabetic neuropathy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410148/
https://www.ncbi.nlm.nih.gov/pubmed/36013364
http://dx.doi.org/10.3390/life12081185
work_keys_str_mv AT smithsasha preventionandmanagementstrategiesfordiabeticneuropathy
AT normahanipasha preventionandmanagementstrategiesfordiabeticneuropathy
AT lanetristan preventionandmanagementstrategiesfordiabeticneuropathy
AT hohenschurzschmidtdavid preventionandmanagementstrategiesfordiabeticneuropathy
AT olivernick preventionandmanagementstrategiesfordiabeticneuropathy
AT daviesalunhuw preventionandmanagementstrategiesfordiabeticneuropathy